Oliver Armitage

Oliver Armitage is a prominent figure in the fields of neuroscience and bioengineering, currently serving as Vice President of Neural Data & Clinical Strategy at Axoft and involved in neuroscience, consciousness, cell therapy, and longevity therapeutics development in Boston, Massachusetts. As a co-founder and senior scientific advisor at BIOS Health Ltd, Oliver Armitage contributes to advancing neural interface technologies that enhance therapeutic outcomes. Previous roles include Technology Fellow at Selvedge Venture and academic research positions at the University of Cambridge and McGill University, focusing on biointerfaces and tissue engineering. Oliver Armitage holds a PhD in Bio-engineering and has completed an M.Phil. and an MEng from the University of Cambridge, specializing in biomaterials and bioengineering.